Items Tagged ‘immunotherapy’
January 6, 2021 · Leave a Comment
Diverse ways regenerative medicine is advancing health care
Regenerative medicine has contributed to patient care in 2020 more than ever before, bolstered by synergies in research, practice and education. Mayo Clinic’s Center for Regenerative Medicine is at the forefront of a biotherapy revolution in which health care advances from treating disease to restoring health. “The centrality of the body to regenerate itself is […]
View full entry Comment on this
Tags: 3D printing, Andre Terzic, artificial intelligence, Atta Behfar, autoimmune disorder, biomedical engineering, CAR T-cell therapy, Center for Regenerative Medicine, clinical research, clinical trials, data science, fetal surgery
January 5, 2021 · Leave a Comment
Looking back on 2020: A successful year of research at Mayo Clinic in Florida
By Advancing the Science contributor 
At Mayo Clinic, Research and Education provide the basis for all we are able to do for patients today. Furthermore, they enable practice transformation as we seek to meet future patient needs. From new capabilities in cell therapy and immunotherapy, to advances in neurodegenerative diseases and studies of the virus that causes COVID-19, research at Mayo Clinic continued […]
View full entry Comment on this
Tags: Alzheimer's disease, Ben Pollock, biomanufacturing, biomarkers, biostatistics, brain, cancer, CAR-T, carbon ion therapy, Center for Regenerative Medicine, chemotherapy, clinical research
August 11, 2020 · Leave a Comment
Expanding CAR T-cell therapy, welcoming Dr. Qin
The first time Hong Qin, M.D., Ph.D., saw images of how chimeric antigen receptor (CAR) T-cell therapy obliterated a tumor, he was captivated and inspired by this revolutionary treatment. As the new director of Regenerative Immunotherapies at Mayo Clinic in Florida, Dr. Qin and his team will play a pivotal role in accelerating the latest […]
View full entry Comment on this
Tags: blood cancer, CAR T-cell therapy, CAR-T, Center for Regenerative Medicine, Hong Qin, immunotherapy, leukemia, Mayo Clinic Cancer Center, regenerative medicine
January 13, 2020 · Leave a Comment
Top ways regenerative medicine is advancing the health care of tomorrow for patients today
Regenerative medicine accelerated from the bench into the practice in new ways in 2019, ushering in an era of care focused on the body’s amazing ability to heal itself. Bolstered by robust research, Mayo Clinic is at the forefront of delivering new therapies that restore form and function to diseased cells, tissues, or organs — […]
View full entry Comment on this
Tags: Andre Terzic, cancer, CAR-T, Center for Regenerative Medicine, clinical trials, immunotherapy, larynx transplant, maternal and fetal medicine, Regenerative Medicine Minnesota, spinal cord injury, transplant
October 2, 2019 · Leave a Comment
Research News Roundup–September 2019
The Mayo Clinic Research News Roundup includes brief summaries and links to research-related news releases from Mayo Clinic in the past month. It also connects readers to associated resources. Read on for more information from Mayo Clinic Research. Medications underused in treating opioid addiction, Mayo Clinic expert says Though research shows that medication-assisted treatment can help […]
View full entry Comment on this
Tags: aging, artificial intelligence, basic science, brain tumor, cancer, cardiology, Center for the Science of Health Care Delivery, chemotherapy, clinical trials, collaboration, coronary bypass, diabetes
June 20, 2019 · Leave a Comment
How are Helper T-Cells Made? And Yes, It’s Important.
By Sara Tiner 
T-cells are having a moment. Well maybe not like Game of Thrones is having a moment, but as stars of the cancer treatment, immunotherapy, T-cells are definitely cool. But what is a T-cell? And how can you get one? Good news! Your body makes T-cells for you, a lot of them. All the time. Wannabe […]
View full entry Comment on this
Tags: basic science, Center for Biomedical Discovery, discovery research, immunotherapy, Virginia Shapiro
February 7, 2019 · Leave a Comment
Eva Galanis, M.D.-Bitten by the virotherapy bug
By Advancing the Science contributor
Every day more than 1,600 Americans die from cancer. Most of them have cancer that can’t be cured with traditional methods — surgery, radiation and chemotherapy. The father of Evanthia Galanis, M.D., was one of them. He died in the late 1990s from melanoma when his daughter was a junior faculty member at Mayo Clinic. “My father would have […]
View full entry Comment on this
Tags: basic science, cancer, clinical trials, Eva Galanis, gene therapy, hematology, immunotherapy, Mayo Clinic Cancer Center, measles virus, oncology, SPORE, virotherapy
January 3, 2019 · Leave a Comment
A vaccine to prevent breast cancer? It’s worth a shot
By Advancing the Science contributor
Each fall, millions of Americans roll up their sleeves for a flu shot, grateful for the quick pinch that may save them from the misery the flu can bring. In the not-too-distant future, there may be a poke with a much bigger payout. Scientists at Mayo Clinic and elsewhere are working on vaccines that could […]
View full entry Comment on this
Tags: breast cancer, immunotherapy, Keith Knutson, Mayo Clinic Cancer Center, ovarian cancer
August 23, 2018 · Leave a Comment
Using the body to recognize and attack cancer
This article originally appeared in the Center for Individualized Medicine blog on July 23, 2018 For as long as he can remember, Saad Kenderian, M.B., Ch.B., wanted to be a physician. Nothing could blunt his resolve –not even when improvised explosive devices, bombs and trappings of war put the medical school in his native Baghdad, […]
View full entry Comment on this
Tags: cancer, CAR-T, Center for Individualized Medicine, gene therapy, immunotherapy, Mayo Clinic Cancer Center, Saad Kenderian
July 25, 2018 · Leave a Comment
Advances in lung cancer immunotherapy and management of immune-mediated adverse events
By Advancing the Science contributor
Over the last few years, immunotherapy using immune checkpoint inhibitors targeting programmed cell death receptor 1 (PD-1) or programmed cell death receptor ligand 1 (PD-L1) has revolutionized the therapeutic approach to advanced-stage non-small cell lung cancer and numerous other malignancies. Monotherapy, using the anti-PD-1 antibody pembrolizumab, is now Food and Drug Administration (FDA) approved for […]
View full entry Comment on this
Tags: clinical trials, immunotherapy, lung cancer, Mayo Clinic Cancer Center, measles virus